Ramiro Garcia-Palazon

Toledo, CM, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Corrigendum to "Transcutaneous spinal cord stimulation plus locomotor training versus sham-stimulation plus locomotor training in chronic spinal cord injury (eWALK): a multicentre, triple-blind, randomised, sham-controlled trial".

Corrigendum to "Transcutaneous spinal cord stimulation plus locomotor training versus sham-stimulation plus locomotor training in chronic spinal cord injury (eWALK): a multicentre, triple-blind, randomised, sham-controlled trial".

Journal: EClinicalMedicine

Published: August 08, 2026

Translation, cross-cultural adaptation and validation of the Spanish version of the Spinal Cord Injury Pain Instrument (SCIPI).

Translation, cross-cultural adaptation and validation of the Spanish version of the Spinal Cord Injury Pain Instrument (SCIPI).

Journal: Spinal cord

Published: October 28, 2025

Transcutaneous spinal cord stimulation plus locomotor training versus sham-stimulation plus locomotor training in chronic spinal cord injury (eWALK): a multicentre, triple-blind, randomised, sham-controlled trial.

Transcutaneous spinal cord stimulation plus locomotor training versus sham-stimulation plus locomotor training in chronic spinal cord injury (eWALK): a multicentre, triple-blind, randomised, sham-controlled trial.

Journal: EClinicalMedicine

Published: October 01, 2025

Tonic Cold Pain Temporal Summation and Translesional Cold Pressor Test-Induced Pronociception in Spinal Cord Injury: Association with Spontaneous and Below-Level Neuropathic Pain.

Tonic Cold Pain Temporal Summation and Translesional Cold Pressor Test-Induced Pronociception in Spinal Cord Injury: Association with Spontaneous and Below-Level Neuropathic Pain.

Journal: Healthcare (Basel, Switzerland)

Published: October 14, 2024

Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury.

Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury.

Journal: Spinal cord

Published: September 22, 2023

Spinal cord injury associated with spontaneous spinal epidural hematoma

Spinal cord injury associated with spontaneous spinal epidural hematoma

Journal: Rehabilitacion

Published: December 19, 2021

Botulinum Toxin: From Poison to Possible Treatment for Spasticity in Spinal Cord Injury.

Botulinum Toxin: From Poison to Possible Treatment for Spasticity in Spinal Cord Injury.

Journal: International journal of molecular sciences

Published: February 23, 2021

Phase II/III placebo-controlled randomized trial of safety and efficacy of growth hormone treatment in incomplete chronic traumatic spinal cord injury.

Phase II/III placebo-controlled randomized trial of safety and efficacy of growth hormone treatment in incomplete chronic traumatic spinal cord injury.

Journal: Spinal cord

Published: December 31, 2020

Treatment of spasticity in spinal cord injury with botulinum toxin.

Treatment of spasticity in spinal cord injury with botulinum toxin.

Journal: The journal of spinal cord medicine

Published: June 06, 2018

Protocol for tizanidine use in infantile cerebral palsy

Protocol for tizanidine use in infantile cerebral palsy

Journal: Anales de pediatria (Barcelona, Spain : 2003)

Published: May 02, 2008

Showing 1-10 of 10

Last Updated: 09/26/2026